These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 15728819)

  • 1. Preventing microalbuminuria in type 2 diabetes.
    Zandi-Nejad K; Brenner BM
    N Engl J Med; 2005 Feb; 352(8):833-4; author reply 833-4. PubMed ID: 15728819
    [No Abstract]   [Full Text] [Related]  

  • 2. Preventing microalbuminuria in type 2 diabetes.
    Mauer M; Fioretto P
    N Engl J Med; 2005 Feb; 352(8):833-4; author reply 833-4. PubMed ID: 15736290
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prevention of microalbuminuria in type 2 diabetes. BENEDICT study].
    Nitschmann S
    Internist (Berl); 2006 Feb; 47(2):199-200; discussion 200. PubMed ID: 16416298
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of microalbuminuria in type 2 diabetes: millimeters or milligrams?
    Glassock RJ
    J Am Soc Nephrol; 2006 Dec; 17(12):3276-8. PubMed ID: 17108313
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing microalbuminuria in type 2 diabetes.
    Ruggenenti P; Fassi A; Ilieva AP; Bruno S; Iliev IP; Brusegan V; Rubis N; Gherardi G; Arnoldi F; Ganeva M; Ene-Iordache B; Gaspari F; Perna A; Bossi A; Trevisan R; Dodesini AR; Remuzzi G;
    N Engl J Med; 2004 Nov; 351(19):1941-51. PubMed ID: 15516697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 7. [Vascular impact of anti-hypertensive treatment and renal protection].
    Mogensen CE
    Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The kidney as a target organ in diabetic patients with arterial hypertension].
    Viberti G
    Drugs; 2003; 63 Spec No 1():31-7. PubMed ID: 12708880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management of hypertensive patients with type 2 diabetes and microalbuminuria.
    Mogensen CE
    Int J Clin Pract Suppl; 1998 Nov; 98():13-20. PubMed ID: 10344026
    [No Abstract]   [Full Text] [Related]  

  • 10. Protein restriction, glomerular filtration rate and albuminuria in patients with type 2 diabetes mellitus: a randomized trial.
    Pijls LT; de Vries H; van Eijk JT; Donker AJ
    Eur J Clin Nutr; 2002 Dec; 56(12):1200-7. PubMed ID: 12494305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension.
    Berrut G; Bouhanick B; Fabbri P; Guilloteau G; Bled F; Le Jeune JJ; Fressinaud P; Marre M
    Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prediction, screening and treatment of renal complications of diabetes].
    Marre M; Larger E
    Rev Prat; 2001 Oct; 51(16):1769-75. PubMed ID: 11795120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antihypertensive treatment in type II diabetes and diabetic nephropathy].
    Chantrel F; Bouiller M; Kolb I; Hannedouche T
    Nephrologie; 2000; 21(2):47-55. PubMed ID: 10798204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
    Bakris GL; Toto RD; McCullough PA
    J Hum Hypertens; 2005 Feb; 19(2):139-44. PubMed ID: 15457206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of blood pressure control and angiotensin-converting enzyme inhibitor therapy on new-onset microalbuminuria in type 2 diabetes: a post hoc analysis of the BENEDICT trial.
    Ruggenenti P; Perna A; Ganeva M; Ene-Iordache B; Remuzzi G;
    J Am Soc Nephrol; 2006 Dec; 17(12):3472-81. PubMed ID: 17082240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group.
    Nelson RG; Bennett PH; Beck GJ; Tan M; Knowler WC; Mitch WE; Hirschman GH; Myers BD
    N Engl J Med; 1996 Nov; 335(22):1636-42. PubMed ID: 8929360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes.
    Ibsen H; Olsen MH; Wachtell K; Borch-Johnsen K; Lindholm LH; Mogensen CE
    J Nephrol; 2008; 21(4):566-9. PubMed ID: 18651547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of benazepril and nicardipine on microalbuminuria in normotensive and hypertensive patients with diabetes.
    De Cesaris R; Ranieri G; Andriani A; Lamontanara G; Cavallo A; Bonfantino MV; Bertocchi F
    Clin Pharmacol Ther; 1996 Oct; 60(4):472-8. PubMed ID: 8873695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.